Literature DB >> 24202372

Trial designs advance to overcome bitter pill of placebo effect.

Monica Heger.   

Abstract

Mesh：

Year:  2013        PMID： 24202372     DOI： 10.1038/nm1113-1353

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach.

Authors:  Maurizio Fava; A Eden Evins; David J Dorer; David A Schoenfeld
Journal:  Psychother Psychosom       Date:  2003 May-Jun       Impact factor: 17.659

2.  Doubly randomized delayed-start design for enrichment studies with responders or nonresponders.

Authors:  Qing Liu; Pilar Lim; Jaskaran Singh; David Lewin; Barry Schwab; Justine Kent
Journal:  J Biopharm Stat       Date:  2012       Impact factor: 1.051

3.  A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

Authors:  Maurizio Fava; David Mischoulon; Dan Iosifescu; Janet Witte; Michael Pencina; Martina Flynn; Linda Harper; Michael Levy; Karl Rickels; Mark Pollack
Journal:  Psychother Psychosom       Date:  2012-01-25       Impact factor: 17.659

4.  An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.

Authors:  Roy N Tamura; Xiaohong Huang
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

5.  Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation.

Authors:  Sandra Lee; John R Walker; Laura Jakul; Kathryn Sexton
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505
  5 in total
  4 in total

1.  The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder.

Authors:  Maurizio Fava
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo Response.

Authors:  Roberto Gomeni; Navin Goyal; Françoise Bressolle; Maurizio Fava
Journal:  Neuropsychopharmacology       Date:  2015-04-21       Impact factor: 7.853

3.  A randomized controlled trial of ganaxolone in posttraumatic stress disorder.

Authors:  Ann M Rasmusson; Christine E Marx; Sonia Jain; Gail M Farfel; Julia Tsai; Xiaoying Sun; Thomas D Geracioti; Mark B Hamner; James Lohr; Richard Rosse; Lanier Summerall; Jennifer C Naylor; Cristine Cusin; Ariel J Lang; Rema Raman; Murray B Stein
Journal:  Psychopharmacology (Berl)       Date:  2017-07-01       Impact factor: 4.530

Review 4.  The placebo effect in asthma.

Authors:  Stefanie Dutile; Ted J Kaptchuk; Michael E Wechsler
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.